(Credit: iStock / Saovade.)

Texas A&M-UTMB Team Identifies Potential Drug to Treat SARS-CoV-2

Story Courtesy of Texas A&M University Research Communications and Public Relations

Feb 23, 2021
"Our team screened more than 30 FDA/European Medicines Agency approved drugs for their ability to inhibit SARS-CoV-2's entry into human cells. The study found bepridil to offer the most potential for treatment of COVID-19. As a result, we are advocating for the serious consideration of using bepridil in clinical tests related to SARS-CoV-2."
Dr. Wenshe Ray Liu, Texas A&M chemist and 2018 Texas A&M Presidential Impact Fellow